转化生物医学

  • 国际标准期刊号: 2172-0479
  • 期刊 h 指数: 16
  • 期刊引用分数: 5.91
  • 期刊影响因子: 3.66
索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 期刊目录
  • 研究圣经
  • 全球影响因子 (GIF)
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 电子期刊图书馆
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

Chlamydia Trachomatis in Rheumatoid Arthritis-A Novel Risk Factor of Secondary Amyloidosis?

Nickolay FS and Anastasiya KT*

Renal involvement is considered to be one of the most severe complications, defining clinical course and prognosis of rheumatoid arthritis (RA). Secondary amyloidosis often leads to renal failure and fatal outcome in patients with RA. Progressive renal function decline in secondary amyloidosis makes extremely important revealing possible predictors. Since effective treatment of secondary amyloidosis has not been developed yet, slowing down the progression of chronic kidney disease by impact on risk factors becomes extremely important. A causal relationship between chronic infection and secondary amyloidosis development have been well known for a long time, but main attention was attached to chronic purulent diseases, such as osteomyelitis, multiple bronchiectasis, etc. Special attention was drawn to such longstanding infection as tuberculosis. Meanwhile there are a number of other cases describing secondary amyloidosis development when chronic infection plays critical role, for example in Reiter's syndrome.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证